Latest news on Laboratorytalk categorised by supplier
Chemicon International
Address:
28820 Single Oak Drive
Temecula
92590
USA
Telephone: (USA) +1 800-437 7500
http://www.chemicon.com
Our RSS feed for news from Chemicon International
Request to receive our free email newsletter each week
Listing of all 22 news releases from Chemicon International:
More kinase assay kits for drug discovery
Serologicals says that Upstate Group, its wholly owned subsidiary, has expanded its Kinease FP product line to include each of the 80 individual kinases that have been validated in the assay
News from Chemicon International (19 July 2006)
Innovative infectious disease detection product
Serologicals announced that Chemicon International, its wholly-owned subsidiary based in Temecula, CA, has launched a new proprietary Amplifluor ID Pan-Enterovirus detection reagent
News from Chemicon International (19 July 2006)
More cost efficient Western blotting detection
Serologicals announced that Upstate, its subsidiary, has released a new, more cost efficient Western blotting detection kit based on its high quality Visualizer western blot detection kit
News from Chemicon International (19 July 2006)
Peptones for cell culture and fermentation
Serologicals announced that Celliance, its wholly-owned subsidiary, is offering a new line of peptones under the brand name of LucraTone
News from Chemicon International (19 July 2006)
Onco-Cyte joins Ex-Cyte family of products
Serologicals announced that Celliance, its wholly-owned subsidiary, has introduced Onco-Cyte cell culture product, the second addition to Ex-Cyte family of products
News from Chemicon International (19 July 2006)
Commercialising human stem cell technology
Chemicon International Enters into a license to commercialise research products utilising human embryonic stem cell technology from Wisconsin Alumni Research Foundation (Warf)
News from Chemicon International (19 July 2006)
Australian-sourced probumin plus bovine albumin
Serologicals announced that Celliance, its wholly-owned subsidiary, is launching a new Bovine Albumin manufactured exclusively from animals originating in the country of Australia
News from Chemicon International (19 July 2006)
License to use RheoSwitch
Chemicon and RheoGene sign license to use RheoSwitch and related technologies within Chemicon's research product lines focused on specialty research markets, including stem cell biology portfolio
News from Chemicon International (14 July 2006)
UCOE polynucleotide wins patent
Serologicals reports that the US Patent and Trademark Office awarded a patent for its recently acquired artificial ubiquitous chromatin opening element (UCOE) polynucleotide and related vectors
News from Chemicon International (14 July 2006)
Embryonic stem cell tissue culture media
Chemicon announces an agreement with Stem Cell Sciences for exclusive manufacturing and marketing of novel, serum-free, embryonic stem cell tissue culture media
News from Chemicon International (14 July 2006)
Celliance acquires UCOE technology from Innovata
UCOE (ubiquitous chromatin opening element) gene expression technology bought from Innovata, a UK based product development company focused on respiratory disease and inhaled therapies
News from Chemicon International (14 July 2006)
Human embryonic stem cell antibody markers
Chemicon International and Axordia have signed an exclusive agreement to co-develop new antibody markers from Axordia's proprietary human embryonic stem (ES) cell lines
News from Chemicon International (14 July 2006)
Licensing agreement for research antibodies
Chemicon and MorphoSys have signed a three-year agreement for the distribution of Hucal-based recombinant research antibodies through Chemicon's worldwide sales network
News from Chemicon International (12 July 2006)
Serologicals announces new UCOE patent
Serologicals reports that the United States Patent and Trademark Office awarded, on 15 November 2005, patent no 6,964,951 with respect to its ubiquitous chromatin opening element (UCOE) technology
News from Chemicon International (12 July 2006)
Expanded distribution agreement with Novo Nordisk
Serologicals announces expanded multi-year distribution agreement with Novo Nordisk; Celliance is exclusive distributor in cell culture marketplace
News from Chemicon International (11 July 2006)
R+D agreement covers cytotoxicity profiling
Chemicon International enters R+D agreement with Cellumen to commercialise a cytotoxicity profiling panel and services designed with Upstate cellular assay reagents and Cellumen system cell biology
News from Chemicon International (11 July 2006)
Agreement to commercialise stem cell products
Chemicon International, a Serologicals subsidiary, has obtained exclusive rights to commercialise, market and distribute stem cell reagents developed at the ASCC to scientists all over the world
News from Chemicon International (17 May 2006)
Serologicals completes acquisition of Cytomyx
Serologicals has completed its previously announced acquisition of Cytomyx, a wholly owned subsidiary of Cytomyx Holdings
News from Chemicon International (17 May 2006)
Media for mouse embryonic stem cell expansion
Chemicon International and Stem Cell Sciences are launching the Esgro Complete product line for murine embryonic stem (ES) cell culture, following the establishment of an exclusive agreement in 2005
News from Chemicon International (17 May 2006)
Agreement covers ReNcell neural stem cell lines
Chemicon International and ReNeuron have entered into an agreement to allow Chemicon to exclusively distribute two of ReNeuron's patented ReNcell neural stem cell lines worldwide for research purposes
News from Chemicon International (21 April 2006)
Chemicon and Cellntec in sales and marketing deal
Guinea-pig polyclonal antibody to nicastrin
